Manufacturing

Avid Bioservices will provide commercial manufacture of an enzyme replacement therapy by Roivant Sciences' Enzyvant subsidiary.

The company aims to add the additional analytical services in the European Union throughout 2018.

An architect's evaluation early in a pharmaceutical facility relocation and design process can help identify potential problems.

The agreement follows the recent opening of WuXi STA's oligonucleotide R&D labs in China and the US.

Automation systems, vehicles, and robots improve efficiency of transporting materials and finished goods in pharmaceutical warehouses.

The companies have partnered to develop and commercialize vectorized antibodies against tau for Alzheimer's and other neurodegenerative diseases.

A new suite for the encapsulation of highly potent drugs will be added.

The study suggests that circumventing evolution in cell factories can enable the commercialization of new biobased chemicals to large-scale.

The company has expanded its single-use manufacturing capabilities at its facility in Fermoy, Ireland.

FDA approves Vertex's cystic fibrosis drug, Symdeko (tezacaftor/ivacaftor and ivacaftor), which is made using a continuous manufacturing process.

Ompi EZ-fill vials and Daikyo Seiko PLASCAP press-fit closures are a confirmed product set for use with Vanrx Pharmasystems' Aseptic Filling Workcells.

Ferring Pharmaceuticals will expand its biologics capabilities at its headquarters and manufacturing site in Saint-Prex, Switzerland.

Honeywell offers an augmented/virtual reality approach to train the industrial workforce.

Unlike current approaches where bioconjugation is typically done following the manufacture of the monoclonal antibody and the cytotoxic drug, the new method begins with the antibody supernatants and eliminates the need for extensive chromatographic purification.

FDA sent a warning letter to Celltrion detailing CGMP violations, including poor microbial contamination control.

The companies have been awarded a collaborative grant of £1.9 million (US$2.6 million) from Innovate UK.

The Multi-Chamber Blister System is a blister package that incorporates Amcor's SafeMix cold form laminate to transport vaccines and sensitive APIs without the need for cool storage.

The company has made an equipment donation to Purdue University's continuous manufacturing research program.

The Honeywell Connected Plant Asset Performance Insight helps manage maintenance and operations by connecting assets and equipment to the cloud and applying analytical models to avoid unplanned downtime.

The Awards honor innovations in drug delivery and packaging, for better patient safety and compliance.

Amgen plans to invest approximately $300 million in a new biomanufacturing plant in the United States.

Layout and supply details must be considered when implementing a fully disposable biopharmaceutical manufacturing process.

A systematic framework and software are needed to implement material traceability in continuous pharmaceutical tablet manufacturing.

The following study describes a methodology to establish, control, and characterize an aerosolized bioburden within a test chamber and determine the settling rate of the bioburden.

New technologies, such as NIR and Raman, enable online measurements of blending and content uniformity in the production of solid dosage forms.